论文部分内容阅读
当世贸大门即将向中国敞开的时候,在新修订的《药品管理法》即将实施之际,在我国医药卫生改革正开展得如火如荼的今天,了解和掌握目前我国国内药品生产企业的发展状况,其中优秀企业的基本情况、GMP的进展情况,国内生产企业之间以及与国际制药企业相比存在哪些差距等是新形势下药监人员、医院管理者、药学人员所必须要了解和掌握的信息。为此,10月11日北京市有关部门组织
When the WTO is about to open its door to China, at the moment when the newly revised Drug Administration Law is about to be implemented, and today the reform of China’s pharmaceutical and healthcare industry is underway in full swing, we should understand and grasp the current situation of the development of the domestic pharmaceutical manufacturers in China The basic information of excellent enterprises, the progress of GMP, the differences between domestic manufacturers and those with international pharmaceutical companies are the information that pharmaceutical supervision personnel, hospital managers and pharmacy personnel must understand and grasp in the new situation. To this end, October 11 Beijing authorities organized